From: Development of a microplate coagulation assay for Factor V in human plasma
Sample | 1-stage assay Activity (Units/ml) | 1-stage assay Extent (Units) | 1-stage assay Initial Rate (mUnits/min) | 2-stage assay Activity (Units/ml) | 2-stage assay Extent (Units) | 2-stage assay Initial Rate (mUnits/min) | Total activity (Units/ml) |
---|---|---|---|---|---|---|---|
NHP | 1.02 | 0.363 | 744.96 | 7.93 | 0.433 | 375.84 | 6.91 |
Patient 1 | 0.36 | 0.404 | 583.80 | 3.84 | 0.432 | 249.96 | 3.48 |
Patient 2 | 0.67 | 0.416 | 704.04 | 5.28 | 0.469 | 323.16 | 4.61 |
Patient 3 | 0.31 | 0.435 | 562.08 | 3.92 | 0.453 | 294.96 | 3.61 |
Patient 4 | 0.39 | 0.435 | 617.04 | 4.14 | 0.462 | 372.60 | 3.75 |
Patient 5 | 0.73 | 0.401 | 641.40 | 5.91 | 0.433 | 354.24 | 5.18 |
Patient 6 | 0.45 | 0.403 | 600.72 | 4.16 | 0.445 | 393.96 | 3.71 |
Patient 7 | 0.49 | 0.395 | 575.40 | 4.89 | 0.449 | 357.48 | 4.40 |
Patient 8 | 0.19 | 0.448 | 489.00 | 2.89 | 0.450 | 330.48 | 2.70 |
Patient 9 | 0.64 | 0.423 | 699.48 | 5.11 | 0.455 | 417.24 | 4.47 |